
UPS acquires Smartways to expand healthcare logistics
Key points
- UPS agreed to acquire Smartways Logistics, expanding its specialised healthcare transportation operations across Australia and New Zealand.
- The acquisition strengthens time-critical delivery capabilities for pharmaceuticals, medical devices, clinical trials and radiopharmaceuticals.
- Completion is expected in the first half of 2027, subject to regulatory approvals, as UPS continues expanding its healthcare logistics network across Asia Pacific.
United Parcel Service (NYSE:UPS) agreed to acquire Smartways Logistics, an Australia- and New Zealand-based healthcare logistics provider, to expand its time-critical transportation capabilities across the region.
Smartways provides specialised transportation services for life sciences, medical devices, clinical trials and radiopharmaceuticals, supporting healthcare customers with urgent and complex delivery requirements.
"As healthcare becomes increasingly complex, logistics plays an even more critical role," said Wilfredo Ramos, UPS executive vice president and chief international, healthcare and supply chain solutions officer.
The acquisition will connect Smartways' regional healthcare logistics operations with UPS's global network, while the purchase price and transaction terms remain undisclosed and completion is expected in the first half of 2027, subject to regulatory reviews and approvals.
UPS Healthcare generated $3 billion in revenue for the third consecutive quarter in Q3 2026, reflecting the company's continued expansion in healthcare transportation, distribution and specialised logistics services.
The planned acquisition follows UPS investments in Asia Pacific, including a new air hub in the Philippines, temperature-controlled freight facilities and expanded healthcare logistics capabilities across the region.

